These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1799614)

  • 1. [The genus Proteus. Pathogenic and epidemiologic aspects].
    Gómez A; Baquero F; Nombela C
    Enferm Infecc Microbiol Clin; 1991; 9(7):425-32. PubMed ID: 1799614
    [No Abstract]   [Full Text] [Related]  

  • 2. [The genus Proteus. Pathogenic and epidemiologic aspects].
    Gómez A; Baquero F; Nombela C
    Enferm Infecc Microbiol Clin; 1991 Oct; 9(8):498-505. PubMed ID: 1805954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proteus bacilli: features and virulence factors].
    Rózalski A; Kwil I; Torzewska A; Baranowska M; Staczek P
    Postepy Hig Med Dosw (Online); 2007; 61():204-19. PubMed ID: 17507868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The genus Proteus: microbiological and clinical aspects].
    Gómez A; Baquero F; Nombela C
    Enferm Infecc Microbiol Clin; 1991 Nov; 9(9):567-75. PubMed ID: 1822710
    [No Abstract]   [Full Text] [Related]  

  • 5. Dienes typing of Proteus strains isolated from barrier-maintained animals.
    Simpson W; Simmons DJ
    Lab Anim; 1976 Oct; 10(10):413-7. PubMed ID: 790014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteus mirabilis Overview.
    Mobley HLT
    Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential virulence factors of Proteus bacilli.
    Rózalski A; Sidorczyk Z; Kotełko K
    Microbiol Mol Biol Rev; 1997 Mar; 61(1):65-89. PubMed ID: 9106365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of Proteus mirabilis strains to the bactericidal action of human serum].
    Frolov AF; Parkhomenko LV; Lukach IG
    Mikrobiol Zh (1978); 1986; 48(3):23-6. PubMed ID: 3077431
    [No Abstract]   [Full Text] [Related]  

  • 9. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the Dienes phenomenon in Proteus typing].
    Plotkowski MC; Suassuna I
    Rev Latinoam Microbiol; 1985; 27(1):49-53. PubMed ID: 3892619
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological application of the Cradock-Watson system for Proteus mirabilis. Comparative study with another system of bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Rubio Peiró R; Piédrola Angulo G
    Rev Latinoam Microbiol; 1985; 27(2):77-81. PubMed ID: 3906814
    [No Abstract]   [Full Text] [Related]  

  • 12. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P; Piccini C; Legnani-Fajardo C
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G
    Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiological application of a new bacteriocin typing procedure for Proteus mirabilis].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Gálvez Vargas R; Piédrola Angulo G
    Rev Latinoam Microbiol; 1985; 27(1):7-10. PubMed ID: 3892620
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
    Alamuri P; Mobley HL
    Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the Dienes phenomenon in epidemiologic practice in intestinal infections].
    Orlov VN
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):56-8. PubMed ID: 4616590
    [No Abstract]   [Full Text] [Related]  

  • 17. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
    Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enteropathogenicity of Proteus mirabilis bacteria and pathogenesis of experimental intestinal infections caused by them].
    Bidnenko SI; Bernasovskaia EP; Anisimova IuN; Barshteĭn IuA; Mel'nitskaia EV
    Mikrobiol Zh (1978); 1985; 47(6):81-8. PubMed ID: 3917194
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of Urease Activity.
    Richmond S; Yep A
    Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteus virulence: involvement of the pore forming alpha-hemolysin (a short review).
    Tóth V; Emódy L
    Acta Microbiol Immunol Hung; 2000; 47(4):457-70. PubMed ID: 11056765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.